Evaluation of the Safety and Efficacy of a Vascular Prosthesis as an Above-Knee Bypass Graft in Patients With PAD

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 10, 2013

Primary Completion Date

May 30, 2016

Study Completion Date

July 18, 2024

Conditions
Peripheral Arterial DiseasePeripheral Vascular Disease
Interventions
BIOLOGICAL

HAV implantation

Patients will be implanted with a Human Acellular Vessel (HAV) as an above-knee femoro-popliteal bypass graft using standard vascular surgical techniques.

Trial Locations (3)

20-081

Clinic of Vascular Surgery and Angiology; Medical University in Lublin, Lublin

70-111

Pomeranian University in Szczecin; Clinic of General, Vascular Surgery and Angiology, Szczecin

51-124

Regional Specialist Hospital in Wroclaw; Clinic of Vascular Surgery, Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

FGK Clinical Research GmbH

INDUSTRY

lead

Humacyte, Inc.

INDUSTRY